At present, the long-term prognosis of patients with acute myocardial infarction (AMI) after emergency percutaneous coronary intervention is the focus of attention, and relevant research is actively investigating the risk factors associated with prognosis. Poor prognosis often exists in Patients with AMI complicated with acute heart failure (AHF). In recent years, some studies have found that blood urea nitrogen/creatinine ratio (BUN/Cr) can better predict the prognosis of patients with AHF than single BUN or Cr. The relationship between long-prognosis of patients with AMI, as one of the common causes of AHF, and BUN/Cr is unknown. The main purpose of this study was to determine whether BUN/Cr has a predictive value for long-term prognosis in patients with AMI complicated with AHF.
Introduction
Acute heart failure (AHF) is one of the most common comorbidities in acute myocardial infarction (AMI) and is associated with adverse prognosis. [1, 2] Both blood urea nitrogen (BUN) and creatinine (Cr) are metabolic end products of nitrogen-containing substances in the human body. As they are small molecules, they can be freely filtered through the glomerulus. Normally, Cr is hardly reabsorbed in the tubules, while approximately 30% to 40% of BUN is reabsorbed. [3] Studies have found that the neurohormonal system was involved in mediating this reabsorption process, which might be enhanced in patients with AHF. [3] Some studies suggest that BUN/Cr, instead of a single BUN or Cr, is associated with the prognosis of patients with AHF. [4] [5] [6] Considering the many primary causes of AHF, AMI is one of them and is the current research focus. [7] The aim of this study was to investigate the correlation between BUN/Cr and the prognosis of patients with AMI complicated with AHF.
Materials and methods
underwent emergency percutaneous coronary intervention (PCI) at ZhongDa Hospital, affiliated to Southeast University, were included in the study. We excluded 11 patients who did not complete the entire follow-up. Briefly, AMI was diagnosed on the basis of the guidelines of the European Society of Cardiology. [1] The diagnosis of AHF was based on the 2016 ESC Guidelines and carried out by at least 1 physician above the level of attendance, in accordance with the patient's symptoms, signs, laboratory findings, and cardiac function evaluation. [7] This study was registered in the Chinese Clinical Trial Registry (Registration No. ChiCTR1800017982) and had been filed with the Ethics Committee of Zhongda Hospital. All the patients provided written informed consent.
Baseline information and laboratory examinations
For all the subjects, general clinical characteristics, laboratory measurements, and imaging examination results were entered. Clinical data were obtained from the hospital medical record system. Laboratory measurements were performed on admission for all the patients. All the patients underwent color Doppler echocardiography (performed at the Color Ultrasound Room, Department of Cardiology, ZhongDa Hospital) within 72 hours of admission.
Follow-up and study endpoints
The endpoint of this study was defined as all-cause mortality. A 1-year follow-up was performed through outpatient visits or ACEI = angiotensin converting enzyme inhibitors, AF = atrial fibrillation, AHF = acute heart failure, ALT = alanine transaminase, ARB = angiotensin receptor antagonist, AST = aspartate transaminase, BMI = body mass index, BNP = brain natriuretic peptide, BUN = blood urea nitrogen, CAD = coronary artery disease, CCB = calcium channel blocker, CD = cerebrovascular disease, CKD = chronic renal disease, COPD = chronic obstructive pulmonary disease, Cr = creatinine, DBP = Diastolic blood pressure, EF = election fraction, GRS = grace risk score HDL = high density lipoprotein, HR = heart rate, LA = left atrium, LDL = low density lipoprotein, LV = left ventricle, RA = right atrium, RV = right ventricle, SBP = systolic blood pressure, TC = total cholesterol, TnI = troponin I, UA = uric acid.
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Data analysis
The 389 subjects were assigned to one of 4 groups according to AHF and a median BUN/Cr of 15.32. Data analysis was performed using SPSS (19.0, International Business Machines Corporation). For quantitative data that followed normal and non-normal distributions, multiple groups were compared using analysis of variance and rank comparison tests, respectively. For categorical variables, the chi-square test was used to compare the composition ratios among the groups. Predictors of 1-year mortality were evaluated using the Cox proportional hazard analysis. Multivariate analysis was respectively performed for indicators, including systolic blood pressure, sex, age, hypertension, and hemoglobin levels, as well as the combination of AHF with BUN/Cr. Hazard ratios (HRs) are presented with their 95% confidence intervals (Cis). The Kaplan-Meier analysis was used to assess the survival rates of the 4 groups. The predictive value of the combination of AHF and BUN/Cr and Grace risk score was assessed using a receiver-operating characteristic (ROC) curve analysis. Statistical significance was defined as a P value of <.05.
Results
After we excluded 11 patients who did not finish the 1-year follow-up, 389 patients remained in the study. The baseline data of the study population are given in Table 1 . The mean age was 62 ± 13 years, and 79% of the patients were male. After the 1-year follow-up, 29 patients died. AHF occurred in 163 patients during hospital stay. According to the combination of AHF and BUN/Cr, the patients were divided into 4 groups as follows: non-AHF + low BUN/Cr (n = 134), non-AHF + high BUN/Cr (n = 92), AHF + low BUN/Cr (n = 61), and AHF + high BUN/Cr (n = 102).
As shown in Table 1 , the AHF + high BUN/Cr was older with lower male ratios, higher prevalence rates of diabetes and cerebrovascular disease, lower hemoglobin level, higher highdensity lipoprotein (HDL) level, and lower triglyceride level than the other groups. At the same time, the AHF + high BUN/Cr group had lower left ventricle election fraction (LVEF) and higher Grace risk score ( Table 1 ). As shown in Table 2 , AHF was independently related to LVEF of <50% (P = .001), brain natriuretic peptide (BNP) level of >100 (ng/L; P < .001), and higher BUN/Cr (P = .018). As shown in Figure 1 , which presents the results of the Kaplan-Meier survival curves, the AHF + high BUN/Cr group had a significantly higher 1-year mortality than the other groups (log-rank test, P = .002). No statistically significant differences were found among the non-AHF + low BUN/Cr, non-AHF + high BUN/Cr, and AHF + low BUN/Cr groups. Through the COX analysis, we found that compared with the non-AHF + low BUN/Cr group, the AHF + high BUN/Cr group had a significantly higher mortality rate (P = .013) after adjustment for sex, age, SBP, heart rate, hypertension, and hemoglobin level, whereas the associations were absent in the non-AHF + high BUN/Cr (P = .617) and AHF + low BUN/Cr groups (P = .251) ( Table 3 ). The ROC analysis for the (Fig. 2) . The Z-test revealed no statistically significant differences between them in the areas under the curve (P = .832, Table 4 ).
Discussion
The kidney and heart have a close bidirectional association that is defined clinically as 5 types of cardiorenal syndrome (CRS). [8] CRS type 1 is characterized by a rapid deterioration of cardiac function that leads to acute kidney injury. [8, 9] Cardiac function in patients with AMI has different degrees of reduction in the short term. [1, 2] Data showed that the incidence of AHF after AMI is 32.4%. [10] BUN level, Cr level, and BUN/Cr are currently recognized indicators of renal function. [9, [11] [12] [13] Studies have shown that when treating patients with AMI complicated with AHF for diuresis and so on, for patients with reduced BUN/Cr, continuation of decongestion therapy is recommended, even though the Cr level has increased significantly. [4, 14] Therefore, BUN/Cr has a greater guiding value for the clinical treatment of AMI patients. The main finding of this study is that AHF combined with elevated BUN/Cr was associated with an increased risk of long-term mortality in patients with AMI. [12, 15] In addition, our findings suggest that the predictive value of BUN/Cr combined with AHF for the prognosis of patients with AMI is not weaker than that of the Grace risk score.
Both the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS) were activated in patients with AHF, which could promote absorption of water and sodium and cause passive reabsorption of BUN in the renal tubules. [4, 12] Activation of the neurohormonal system could also lead to renal vasoconstriction and decreased glomerular filtration rate and BUN excretion. [12] Furthermore, insufficient blood volume secondary to low cardiac output stimulates the release of arginine vasopressin (AVP), which can facilitate the reabsorption of BUN in the collecting duct. [16, 17] For the reasons that the Cr was freely filtered through the glomerulus and not reabsorbed and the single BUN had many influencing factors, many studies believe that BUN/Cr is useful for treating AHF patients. [4] For patients with AMI complicated with AHF, higher BUN/Cr reflects a more active neurohormonal system. It is currently widely believed that activation of the RAAS and SNS systems is associated with adverse prognosis. [18] [19] [20] [21] Yoichi et al reported that BUN/Cr, but not BUN or Cr individually, is linked with an increased risk of mortality in AHF patients. [4] Gotsman et al also Figure 2 . Receiver operating characteristic curves for different indicators to predict longterm mortality for AMI patients. AHF = acute heart failure, BUN = blood urea nitrogen, Cr = creatinine. Adjusted for age, sex, SBP, heart rate, Hypertension, Hemoglobin. AHF = acute heart failure, BUN = blood urea nitrogen, Cr = creatinine, HR = hazard ratio.
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believed that in patients with AHF, admission BUN/Cr was a predictor of worse 1-year and long-term (mean follow-up of 6.5 years) mortality. [22] Brisco et al also found that a significant association exists between elevated admission BUN/Cr and increased mortality. [23] For patients with AMI without AHF, we found no correlation between BUN/Cr and prognosis. [24] We considered that this might be related to some factors that may have affected the baseline BUN/Cr, such as high protein diet and hepatic insufficiency. [25] In the analysis of risk factors for the incidence of AHF in patients with AMI, we found that LVEF of <50%, BNP level of >100 ng/L, and higher BUN/Cr were significantly associated with the incidence of AHF. LVEF had a significant value for evaluating heart function, and decreased LVEF is closely associated with adverse prognosis. Some studies have suggested that the specific value of elevated BNP level has no significant correlation with prognosis, which needs further study. [26] [27] [28] Our study found that BUN/Cr has a predictive value for the development of AHF in patients with AMI and can be used for risk stratification in patients with AMI.
Studies have shown that the Grace risk score can be used to predict not only in-hospital mortality in patients with AMI but also long-term prognosis. Through an analysis, we found that for patients with AMI, the predictive value of the combination of AHF and BUN/Cr for prognosis is not weaker than that of the Grace risk score. Considering that the Grace risk score is based on a large number of cases, the predicted value of BUN/ Cr needs further research to demonstrate. Several studies have previously shown a close association of Na + with heart failure. As shown in this study, Na + levels in non-AHF + high BUN/Cr group and AHF + high BUN/Cr group were lower than those in non-AHF + low BUN/Cr group, while the remaining pair-wise comparisons of Na + levels did not indicate statistically significant differences. Univariate analysis showed a correlation between Na + and the incidence of AHF. However, after multivariate analysis, such a correlation was not present. We postulate that this finding could be due to the larger fluctuations in Na + levels. We intend to conduct a future study using a larger patient population in order to achieve higher accuracy.
The present study had several limitations. First, as this was a single-center clinical study, population limitations may exist in the cases studied. Second, the predictive value of BUN/Cr for long-term outcomes in patients with AMI must be examined in a larger sample size. Third, as this was an observational study, although a multifactor analysis was performed, other confounding factors might still be existing. Furthermore, only data from a single BUN/Cr test were available at admission; no repeated testing was performed during the long-term follow-up, which may have resulted in biases in the study results.
Conclusion
The combination of AHF with an elevated BUN/Cr admission is linked with an increased risk of mortality in patients with AMI. The predictive value of BNU/Cr for prognosis in patients with AMI is not independent of AHF. In addition, the study also shows that for patients with AMI, the predictive value of the combination of AHF and BUN/Cr for prognosis is not weaker than that of the Grace risk score. AHF = acute heart failure, AUC = area under curve, BUN = blood urea nitrogen, Cr = creatinine, GRS = grace risk score.
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